This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Absolute Antibody
product type :
antibody
product name :
Anti-PCNA [PC10]
catalog :
Ab00605-2.0
quantity :
200 μg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
PC10
The same clone is also sold as:
The same clone is also sold as:
- Santa Cruz Biotechnology: sc-56, sc-56 HRP, sc-56 AC
- Exbio: 11-182-C100, 1P-182-T025, 1P-182-T100
- Cell Signaling Technology: 8580, 2586
- Invitrogen: 13-3900, PCNA01, 13-3940, MA5-11358, 752-9910-82, MA5-11355
- Novus Biologicals: NBP2-80905, NB500-106
- Bio-Rad: VMA00018
- BioLegend: 307904, 307915, 307902, 307901, 307912, 307909, 307908
- MyBioSource: MBS245134
- Abcam: ab265585, ab201674, ab29, ab201672
- GeneTex: GTX20029
- BD Biosciences: 555566, 555567
- Abnova: MAB12946
- OriGene: AM10035PU-S, AM10035FC-N, MO20014-100, AM10035PU-N, SM1421P, TA309795
- Acris Antibodies: SM1421P
- Dako: M0879
reactivity :
human
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, flow cytometry
product information
Product Name :
Anti-PCNA [PC10]
Catalog Number :
Ab00605-2.0
Target :
PCNA
Antibody Species :
Mouse
Isotype :
IgG2a
LCFormat :
kappa
Target Synonyms :
Proliferating cell nuclear antigen; cyclin or polymerase delta accessory protein
Display Amount :
200 μg
PriceGBP :
285
PriceEUR :
315
Product Type :
Primary Antibody
Clonality :
Monoclonal
ApplicationCodesClone :
FC; IHC; IF; IP; WB
Immunogen :
Protein A-PCNA fusion obtained from pC2T.
Available Custom Conjugation Options :
AP, HRP, Fluorescein, APC, PE, Biotin Type A, Biotin Type B, Streptavidin, FluoroProbes 647H, Atto488, APC/Cy7, PE/Cy7
UniprotAccessionNo :
P12004
Product Description :
This is a recombinant monoclonal antibody.
company information
Absolute Antibody
Wilton Centre
Redcar
Cleveland
TS10 4RF
Redcar
Cleveland
TS10 4RF
info@absoluteantibody.com
https://absoluteantibody.com/1-617-377-4057
headquarters: United Kingdom
questions and comments